Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 889-900 of 1386 results.
"This study aimed to apply a Bayesian probabilistic framework to the Intravenous vs. Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial data to evaluate the likelihood of benefit for each vascular access method while incorporating various prior beliefs” Vallentin et al (2025).
"Therefore, we aimed to compare the chemoport and Hickman central venous catheters (CVCs) as representative devices used in patients with hematological cancer” Han et al (2025).
"Use of NIR imaging for identification of superficial, peripheral veins is feasible in healthy beagles and hounds, regardless of shaving and administration of dexmedetomidine. This technology could be useful in other clinical scenarios” Bowden et al (2025).
"This protocol offers a practical educational method for an ultrasound mastery learning program, enhancing needle identification, guidance, safety, and procedural success in venous and arterial cannulation” Ostroff and Moureau (2025).
"Despite widespread adoption of these innovations, current guidelines often confuse puncture and exit sites, leading to outdated recommendations. For example, guidelines labeling femoral or jugular access as high-risk often fail to differentiate between venipuncture and exit locations” Annetta et al (2025).
"Virtual visits demonstrate noninferiority to in-person visits based on the incidence of catheter complications and readmission rates. New evaluation techniques need to be developed for this high-risk populations in virtual visits to establish effective and safe patient management” Munroe et al (2025).
"Genta-EDTA-Na2 used as intra-catheter locks may be a promising anti-biofilm candidate to be studied in a randomized controlled trial” Lebeaux et al (2025).
"Tigecycline meets the UK YCD criteria of ≤5% degradation limit, indicating its suitability for both intermittent and continuous 24-h infusion in OPAT programs” Wolie et al (2025).
"We conclude that S-OPAT is a viable model of care, demonstrating favourable clinical outcomes, although some safety concerns have been reported. The growing care demand now and in the future urges further development of S-OPAT care" Maaskant et al (2025).
"We aimed to investigate the relationship between the total noradrenaline dose administered via PIVCs and the development of phlebitis by considering the influence of noradrenaline as a time-dependent covariate” Yasuda et al (2025).
"Post-procedure chest X-ray to confirm this access indicated that this central venous catheter (CVC) was misplaced, with its tip placed into the right axillary vein" Arif et al (2025).
"OPAT appears to be safe and effective for IE patients, with low mortality and relapse rates. However, increased readmission rates and IV-line complications warrant careful patient selection and monitoring. Further prospective trials are needed to refine OPAT protocols" Ashraf et al (2025).
